Skip to contentC
Cannabis Suisse Corp.
C
CSUICannabis Suisse Corp. Q3 2025 · 10-Q
Revenue$7.50K$7.50K±0.0% vs Q3 2024 Net Income$29.52K$29.52KN/M vs Q3 2024 EPS Diluted$0.00$0.00— vs Q3 2024 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cannabis Suisse Corp. · CIK 1680132 · Engraved from SEC EDGAR
Operating Cash Flowderived-$11,450N/M Margins · derivedGross margin1.9%−6.4 pt vs Q3 2024
Operating margin-890.5%−52.4 pt vs Q3 2024
Net margin393.5%+1299.9 pt vs Q3 2024
ended Feb 28, 2025 · filed Apr 17, 2025 · 48 d after period end